Key result
A 20-year-old male with COVID-19 developed severe acute hemolytic anemia, acute myocarditis, and cardiogenic shock, but achieved marked left ventricular functional recovery with supportive care.
Why the study?
Acute myocarditis remains an unexplored area in COVID-19 patients that could influence long-term outcomes, with no case of severe hemolytic anemia with stress cardiomyopathy or acute myocarditis formally reported in the literature.
Case Report (n=1)
No
This case highlights a rare presentation of COVID-19 involving severe hemolytic anemia, acute myocarditis, and cardiogenic shock that resolved with supportive medical therapy.
May support expectant management in rare young COVID-19 myocarditis cases with shock; hypothesis-generating and should not change practice.
Coronavirus disease 2019 (COVID-19) cases are on the rise globally, and mortality- and survival-related data are emerging every day. In addition, upcoming reports are suggestive of increased risk of cardiac ailments in high-risk patients. In the context of cardiac involvement, acute myocarditis has become one of the unexplored areas in COVID-19 patients, which could influence the long-term outcomes. In this report, we present a rare case that warrants further study on the subject due to the paucity of data in the literature. To date, no case of severe hemolytic anemias with stress cardiomyopathy/acute myocarditis in a patient of COVID-19 has been formally reported in the literature. The bedside echocardiogram had shown a possibility of acute myocarditis. The patient's marked left ventricular (LV) functional recovery without coronary intervention further corroborates the same. Clinicians should be aware of the diversity of cardiovascular/hematological complications, as well as focused cardiac ultrasound study and the importance of echocardiography as a good screening modality for cardiovascular and hematological complications of COVID-19 infection.
No takes yet. Share an insight, caveat, or question.
Singhavi et al. (2020) conducted a case report in COVID-19 with hemolytic anemia, acute myocarditis, and cardiogenic shock (n=1). Supportive care (blood transfusion, noradrenaline, low molecular weight heparin, methylprednisolone) was evaluated on Clinical recovery. A 20-year-old male with COVID-19 developed severe acute hemolytic anemia, acute myocarditis, and cardiogenic shock, but achieved marked left ventricular functional recovery with supportive care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: